GuyCleageJonesMD
Radiation Oncology • Reno, NVBreast Cancer, Gynecologic Cancer, Head & Neck, Thoracic Cancer
Medical Director, Oncology Nevada
Dr. Jones is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10745 Double R Blvd
# 13
Reno, NV 89521Phone+1 775-322-7811Fax+1 775-322-1431
Summary
- Dr. Guy Jones is a Radiation Oncologist in Reno, NV where he serves at the Medical Director for Oncology Nevada. He earned his medical degree from Rutgers University and completed his training in Radiation Oncology at the National Cancer Institute. He has been in practice for 10 years and specializes in cancers of the breast, head & neck, lung, and gynecological malignancies. He also treats a number of non-cancerous (benign) conditions including Dupuytren's contracture, arthritis, bursitis, and plantar fasciitis.
Education & Training
National Capital ConsortiumResidency, Radiation Oncology, 2011 - 2015
Spokane Teaching Health CenterInternship, Transitional Year, 2010 - 2011
Rutgers New Jersey Medical SchoolClass of 2010
Certifications & Licensure
ID State Medical License 2021 - 2026
TX State Medical License 2014 - 2026
NV State Medical License 2021 - 2025
OR State Medical License 2015 - 2025
WA State Medical License 2015 - 2025- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- American Brachytherapy Society LDR Scholar 2015
- American Brachytherapy Society HDR Scholar 2015
- Roentgen Resident/Fellow Research Award recipient Radiological Society of North America, 2014
Publications & Presentations
PubMed
- 114 citationsTherapeutic hyperthermia: The old, the new, and the upcoming.Matthew Mallory, Emile Gogineni, Guy C. Jones, Lester Greer, Charles B. Simone
Critical Reviews in Oncology/hematology. 2016-01-01 - 40 citationsPrimary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients.Guy C. Jones, Jason D. Kehrer, Jenna M. Kahn, Bobby N Koneru, Ram Narayan
Clinical Lung Cancer. 2015-11-01 - Are the Conclusions of Z11 Relevant to Community PracticeGuy C. Jones, Tuo Dong, Charles B. Simone, Susan F. Stinson
Clinical Breast Cancer. 2015-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
